Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Sanofi 13.284, AstraZeneca 15.384.
Sanofi vs AstraZeneca: Revenue Comparison
Sanofi (SNY) and AstraZeneca (AZN) are peers in Vaccines. Sanofi reported revenue of $13.3B as of Q2 2026, compared with $15.4B for AstraZeneca. AstraZeneca leads on revenue.
Sanofi's gross margin is 75.5% versus 83.6% for AstraZeneca. Sanofi's net margin is 2.8% versus 16.3% for AstraZeneca.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Sanofi, AstraZeneca.| Metric | Sanofi | AstraZeneca |
|---|---|---|
| Market Cap | - | - |
| Revenue | $13.28B | $15.38B |
| Cost of Revenue | $3.26B | $2.52B |
| Gross Profit | $10.03B | $12.86B |
| Operating Income | $2.58B | $3.16B |
| Net Income | $370.00M | $2.51B |
| R&D Expense | $2.41B | $4.05B |
| Earnings Per Share | $0.15 | $1.59 |
| Gross Margin | 75.5% | 83.6% |
| Operating Margin | 19.4% | 20.6% |
| Net Profit Margin | 2.8% | 16.3% |
| Free Cash Flow | $4.22B | $2.13B |
| Cumulative Free Cash Flow | $51.81B | $121.22B |
| Operating Cash Flow | $5.85B | $2.89B |
| Cash & Equivalents | $6.86B | $4.89B |